Tender for Supply of exclusive medicinal products with active substances Bimekizumab, Fenfluramine, Inebilizumab, Lumasiran, Mirikizumab, Pitolisant, Tafasitamab, Tensioactive Pulmonar Porcino, Tuberculina, Velmanasa and Vutrisiran from the pharmaceutical laboratories Alnylam Pharmaceuticals Spain, S.L., Amgen, S.A., Biomarin Pharmaceuticals Spain, S.L., Chiesi España, S.A.U., Incyte Biosciences, Iberia, S.L.

The tender identified with expedient 719739-2025 is related to the sector Undefined. This tender, published on January 21, 1970 and last updated on January 21, 1970, aims to Exclusive medicines with active substances Bimekizumab, Fenfluramine, Inebilizumab, Lumasiran, Mirikizumab, Pitolisant, Tafasitamab, Tensioactive Pulmonar Porcino, Tuberculin, Velmanase and Vutrisiran. The estimated value of the contract is €2,880,262.80 , with a budget excluding taxes of No budget defined. The procedure modality is Undefined, and currently its status is Awarded.

This tender is located in Murcia España, ES, Región de Murcia, ES. The main source of this information is Tenders Electronic Daily .

The tender is classified under several CPV codes, including CPV, among others Other nervous system medicinal products (No code: 33661700), among others.